These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12353705)

  • 1. In vitro activity of phytosphingosines against Malassezia furfur and Candida albicans.
    Nenoff P; Haustein UF
    Acta Derm Venereol; 2002; 82(3):170-3. PubMed ID: 12353705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of Malassezia species by pharmacological concentrations of polidocanol.
    Mayser P; Gründer K
    Mycoses; 1995; 38(1-2):23-7. PubMed ID: 7637678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifungal activity of a coal tar gel on Malassezia furfur in vitro.
    Nenoff P; Haustein UF; Fiedler A
    Dermatology; 1995; 191(4):311-4. PubMed ID: 8573928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Pityrosporum ovale (Malassezia furfur) to human androgenic steroids.
    Brasch J
    Mycopathologia; 1993 Aug; 123(2):99-104. PubMed ID: 8264774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polidocanol sensitivity--a possible tool in the differentiation of Malassezia spp.
    Mayser P; Haze P; Pickel M
    Mycoses; 1997 Dec; 40(9-10):391-5. PubMed ID: 9470429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
    Sancak B; Ayhan M; Karaduman A; Arikan S
    Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia.
    Hammer KA; Carson CF; Riley TV
    J Med Vet Mycol; 1997; 35(5):375-7. PubMed ID: 9402533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.
    Youngchim S; Nosanchuk JD; Chongkae S; Vanittanokom N
    Arch Dermatol Res; 2017 Jan; 309(1):47-53. PubMed ID: 27885419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriacitrin--a potent UV filter produced by Malassezia furfur and its effect on human skin microflora.
    Machowinski A; Krämer HJ; Hort W; Mayser P
    Mycoses; 2006 Sep; 49(5):388-92. PubMed ID: 16922790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
    Rukayadi Y; Hwang JK
    Lett Appl Microbiol; 2007 Feb; 44(2):126-30. PubMed ID: 17257249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
    Far FE; Al-Obaidi MMJ; Desa MNM
    J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine antivitamins--an opportunity of therapy of fungal infections caused by Malassezia pachydermatis and Candida albicans.
    Siemieniuk M; Czyzewska U; Strumilo S; Tylicki A
    Mycoses; 2016 Feb; 59(2):108-16. PubMed ID: 26691773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
    Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
    Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphatidate phosphatase activity from the yeast Saccharomyces cerevisiae by sphingoid bases.
    Wu WI; Lin YP; Wang E; Merrill AH; Carman GM
    J Biol Chem; 1993 Jul; 268(19):13830-7. PubMed ID: 8314751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of lithium succinate against Malassezia furfur.
    Nenoff P; Haustein UF; Münzberger C
    Dermatology; 1995; 190(1):48-50. PubMed ID: 7894097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro.
    Payne CD; Ray TL; Downing DT
    J Invest Dermatol; 1996 Mar; 106(3):549-52. PubMed ID: 8648192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Activity of Thapsia villosa Essential Oil against Candida, Cryptococcus, Malassezia, Aspergillus and Dermatophyte Species.
    Pinto E; Gonçalves MJ; Cavaleiro C; Salgueiro L
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28937623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.
    Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C
    Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
    Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
    Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.